- Home
- DXCM
DXCM
DexCom Inc.
as 09-17-2025 4:00pm EST
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 31.7B | IPO Year: | 2005 |
| Target Price: | $99.89 | AVG Volume (30 days): | 4.5M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 19 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.43 | EPS Growth: | -11.42 |
| 52 Week Low/High: | $57.52 - $93.25 | Next Earning Date: | 10-23-2025 |
| Revenue: | $4,300,800,000 | Revenue Growth: | 9.30% |
| Revenue Growth (this year): | 17.03% | Revenue Growth (next year): | 15.59% |
Stock Insider Trading Activity of DexCom Inc. (DXCM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Malady Kyle | DXCM | Director | Sep 5 '25 | Sell | $80.86 | 667 | $53,933.62 | 22,667 | |
| Stern Sadie | DXCM | EVP, Chief HR Officer | Sep 4 '25 | Sell | $80.00 | 1,466 | $117,280.00 | 105,223 | |
| Sylvain Jereme M | DXCM | EVP, Chief Financal Officer | Sep 2 '25 | Sell | $74.17 | 4,824 | $357,796.08 | 118,657 | |
| Brown Michael Jon | DXCM | EVP, Chief Legal Officer | Aug 15 '25 | Sell | $80.29 | 500 | $40,145.00 | 94,102 | |
| FOLETTA MARK G | DXCM | N/A | Aug 15 '25 | Sell | $81.28 | 2,750 | $222,902.82 | 51,316 |
Latest DexCom Inc. News
DXCM Breaking Stock News: Dive into DXCM Ticker-Specific Updates for Smart Investing
Simply Wall St.
15 hours ago
Does DexCom's Interim Leadership Shift Alter the Strategic Outlook for DXCM?
StockStory
a day ago
1 Healthcare Stock Worth Your Attention and 2 We Brush Off
Insider Monkey
a day ago
Wall Street is Bullish on DexCom (DXCM), Here’s Why
MedTech Dive
2 days ago
Insulet names new CFO; Dexcom CEO on leave
StockStory
2 days ago
DexCom (DXCM) Stock Is Up, What You Need To Know
Business Wire
3 days ago
Dexcom Spotlights Upcoming Feature Launches, Improved Health Outcomes and Cost-Effectiveness With Dexcom Glucose Biosensing at EASD 2025
StockStory
7 days ago
Oscar Health, Penumbra, DexCom, Merit Medical Systems, and HCA Healthcare Shares Are Falling, What You Need To Know
Business Wire Videos
8 days ago
Dexcom Launches Its First Open Call to Uncover the Next Diabetes Advocates Ahead of World Diabetes Day
Compare DXCM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DXCM DexCom Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.